PHY34
CAS No. 2130033-55-3
PHY34 ( —— )
产品货号. M13391 CAS No. 2130033-55-3
PHY34 是一种有效的自噬抑制剂,通过抑制晚期自噬而产生细胞毒性作用(MDA-MB-435 IC50=23 nM,MDA-MB-231 IC50=5.2 nM);破坏溶酶体功能,显着抑制中空纤维中癌细胞系的生长,并减少异种移植模型中的卵巢肿瘤负担。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2009 | 有现货 |
|
| 5MG | ¥3151 | 有现货 |
|
| 10MG | ¥4674 | 有现货 |
|
| 25MG | ¥7501 | 有现货 |
|
| 50MG | ¥10206 | 有现货 |
|
| 100MG | ¥13608 | 有现货 |
|
| 500MG | ¥27378 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PHY34
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PHY34 是一种有效的自噬抑制剂,通过抑制晚期自噬而产生细胞毒性作用(MDA-MB-435 IC50=23 nM,MDA-MB-231 IC50=5.2 nM);破坏溶酶体功能,显着抑制中空纤维中癌细胞系的生长,并减少异种移植模型中的卵巢肿瘤负担。
-
产品描述PHY34 is a potent autophagy inhibitor with cytotoxic effects by inhibiting autophagy at a late stage (MDA-MB-435 IC50=23 nM, MDA-MB-231 IC50=5.2 nM); disrupts lysosomal function, significantly inhibits the growth of cancer cell lines in hollow fibers, as well as reduces ovarian tumor burden in a xenograft model.
-
体外实验Cell Viability Assay Cell Line:OVCAR8, OVCAR3, HT-29, MDA-MB-435, MDA-MB-231, IOSE80, FT33Concentration:0.001 nM-50 μM Incubation Time:72 h Result:Inhibited the growth of various cancer cells with IC50 values of 4 nM(OVCAR8, OVCAR3), 43.3 nM(HT-29) , 23 nM(MDA-MB-435) , 5.2 nM(MDA-MB-231).Exhibited no toxicity to IOSE80 and FT33 (IC50 >50 μM).Cell Viability Assay Cell Line:H4 Concentration:0.01 nM-2 μM Incubation Time:72 h Result:Inhibited mutant cell with an IC50 value of 246 pM that was 1000-fold more potent than HTP-013(434 nM).Conferred resistance in V8231 mutation and no impact activity in T216A mutation.Apoptosis Analysis Cell Line:OVCAR8, OVCAR3 Concentration:10 nM, 100 nM Incubation Time:72 h Result:Increased the number of cells in early and late apoptosis in OVCAR8 and OVCAR3 at 10 nM and 100 nM, respectively. Cell Autophagy Assay Cell Line:Hela Concentration:9.31 fM-20 μM Incubation Time:4 h Result:Sustained high levels of LC3B puncta with an EC50 value of 2 nM.Inhibited autophagy with an EC50 value of 3.9 nM.Cell Autophagy Assay Cell Line: OVCAR3 Concentration:5 nM Incubation Time:4 h Result:Inhibited autophagy with an ED50 value of 6.29 nM, and was more potent than bafilomycin A1 (HY-100558) with an ED50 value of 29.1 nM.Western Blot Analysis Cell Line:OVCAR8, OVCAR3, OVCAR4 Concentration:10 nM, 100 nM Incubation Time:48 h, 72 h Result: Increased cPARP levels in OVCAR8 after 48 h at 10 nM, in OVCAR4 and OVCAR3 after 72 h at 100 nM, respectively. Reversed the conversion of PARP to cPARP combined with RAP (HY-10219) of 1 μM.Western Blot Analysis Cell Line:OVCAR8, OVCAR3, OVCAR4 Concentration:10 nM Incubation Time:24 h, 48 h, 72 h Result:Promoted histone H3, LAMP1/2, ACSS2, and PCNA nuclear protein accumulation at 48 h.Reduced expression of KPNA2 (Karyopherin subunit alpha 2) with time-dependent manner.
-
体内实验Animal Model:OVCAR8-induced xenograft models in female nude mice.Dosage:0.75 mg/kg, three times a week for three weeks Administration:Intraperitoneal injection (i.p.)Result:Decreased tumor burden based on average abdominal radiant efficiency with no gross toxicity through analysis of fluorescence imaging.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy
-
研究领域——
-
适应症——
化学信息
-
CAS Number2130033-55-3
-
分子量522.506
-
分子式C28H26O10
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1(OC2C(OC(C(C2O1)O)OC3=C4COC(=O)C4=C(C5=CC=CC=C53)C6=CC7=C(C=C6)OCO7)CO)C
-
化学全称9-(benzo[d][1,3]dioxol-5-yl)-4-(((3aS,4R,6S,7R,7aR)-7-hydroxy-4-(hydroxymethyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl)oxy)naphtho[2,3-c]furan-1(3H)-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Young AN, et al. Mol Cancer Ther. 2018 Jul 17. pii: molcanther.1195.2017.
产品手册
关联产品
-
Glaucocalyxin B
Glaucocalyxin B 是一种从 Rabdosia japonica 中分离出来的二萜类化合物,具有抗癌和抗肿瘤活性。它降低 HL-60 细胞的生长(IC50:5.86 μM)。
-
Sulfalen
磺胺嘧啶是一种长效磺酰胺抗生素,用于治疗慢性支气管炎、尿路感染和疟疾。
-
Sulfadoxine
磺胺多辛(Sulphadoxine)是一种长效磺酰胺,通常与其他化合物联合使用,用于治疗呼吸道、泌尿道和疟疾感染。
021-51111890
购物车()
sales@molnova.cn

